Investors login
Menu
Investors login
Menu

News: 2021

Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms

January 06, 2021
• First joint CriVac® vaccine candidate to target receptor-binding domain of SARS-CoV-2 • Evaluation of Cristal's CliCr® and I...
Read more
Cristal Therapeutics and Intravacc Announce Strategic Collaboration to Advance Novel Vaccine Platforms
Previous 1 2 3
Archives
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
News
MIMETAS Contributes with Human Organ-on-Chip Data to IND Application by argenx
July 11, 2024
The preclinical collaboration focused on investigating the effects of a novel candidate in a human in vitro disease assay in MI...
More news

Home > News > Archive

Contact
Businesspark Berg en Bosch
Prof. Bronkhorstlaan 10, building 92
3723 MB Bilthoven
T +31 (0)30 - 229 60 90
F +31 (0)30 - 229 60 99
info@aglaia-oncology.com
Aglaia Management B.V. is registered with the Trade Register of the Chamber of Commerce and Industry under number 54970857.
© 2025 Aglaia Oncology Funds | Privacy | Sitemap
Aglaia Oncology Funds